Evaluating an injection molding supplier for a regulated medical device program is a process-validation exercise, not a certificate check. The core question is whether the molder can demonstrate control over the molding process itself, the supporting quality system, and the sub-tier material chain. A MedAccred Plastics Injection Molding audit, for example, assesses compliance with customer specifications and MedAccred requirements while examining the end-to-end manufacturing supply chain, tooling, quality control, support functions, and process validation [1]. The evaluation therefore needs to distinguish between broad quality management system audits and deep process-specific audits. David Vazquez of Becton Dickinson describes the difference: a QMS audit is broad but shallow, while a MedAccred audit is deep in a process area, a mile deep and an inch wide [4]. That distinction should shape the supplier qualification workflow.

The Evaluation Workflow Starts With Risk and Scope

A defensible evaluation begins by defining what the component does and what failure would mean. The Global Center for Medical Innovation frames this as a question of annoyance versus real risk: if a component fails, is it an annoyance or does it pose real risk, such as a component's material entering a sterile environment or the patient's anatomy, like a screw or complete implant [8]. That risk classification drives the required depth of supplier controls. For low-risk components, ISO 9001 may be acceptable in some programs, but for critical components and the materials from which they are made, such as a polymer, metal or alloy, manufacturers of record should insist on ISO 13485 suppliers [8]. The evaluation criteria should be written from the device manufacturer's regulatory obligations, then quotes that cannot meet that bar should be rejected [6]. The manufacturer retains ultimate responsibility for all functions within its own quality management system, including the purchasing process, even when oversight activities are carried out by an independent party [7].

The IMDRF guidance on choosing and evaluating suppliers describes a lifecycle approach that includes planning; selecting, evaluating, and accepting potential suppliers; and monitoring them [7]. Manufacturers should assess business and operational capabilities, including technological competence, projected growth, and disaster-planning strategies [7]. No supplier can be fully approved until all selection criteria have been met and all necessary controls established, and a formal record of acceptance signed by an authorized person must document the supplier name, date, expiry, scope, and any restrictions [7]. This record-keeping requirement means the evaluation workflow must produce auditable outputs, not just a shortlist.

Process Validation Depth Separates Serious Molders

Injection molding for medical devices typically requires formal process validation through Installation Qualification, Operational Qualification, and Performance Qualification [6]. The MedAccred audit criteria cover maintenance, calibration, qualified personnel and training, and the critically important phases of process validation [1]. A supplier must have a documented Master Validation Plan defining the strategic approach to validation and addressing the requirements for each phase [1]. Common non-conformances found during initial MedAccred audits include gaps in the Master Validation Plan and discrepancies between actual machine settings and the molding set-up sheet, where settings must lie within the validated process window with proper tolerances and process alarm settings [1].

Evaluation should probe validation maturity directly. Questions worth asking include whether the supplier has documented IQ/OQ/PQ experience, design of experiments capability, and clear protocol ownership [6]. The MedAccred program aligns its audit criteria with 21 CFR Part 820, GHTF/SG3/N99-10:2004 Edition 2, and ISO 13485 [1]. The audit criteria also cover maintenance, calibration, qualified personnel and training, and the phases of process validation [1]. A supplier's ability to explain how its validation approach maps to those standards, and to show the Master Validation Plan during a site visit, is a stronger signal than a certificate displayed in a lobby. The evaluation should also confirm that the supplier's own sub-tier controls include selection, evaluation and approval, product qualification, procurement, product acceptance, performance measurement and monitoring, nonconforming product and CAPA processes, and change control [5].

Supplier Selection Factors From the EFS Biocompatibility Program

The MDIC Early Feasibility Studies Biocompatibility Program recommends obtaining comprehensive material information from suppliers, including sub-tier suppliers, using non-disclosure agreements for proprietary information when necessary [2]. The supplier should be willing to share all manufacturing processes and sub-tier suppliers, excluding proprietary information, for a given component to address gaps and deficiencies identified by regulators [2]. The program also recommends evaluating the type of quality system at the manufacturing facility, since sourcing raw materials from suppliers manufacturing in a GMP-compliant environment provides assurance that processes used to make the materials are reproducible and quality is controlled [2]. A cross-functional selection team should include clinical practice, engineering, microbiology, sterilization, biocompatibility, regulatory, material science, procurement, and supplier quality expertise [2]. The program also recommends prioritizing suppliers with a solid history of clinical relevance, including both benefits and risks, regulatory compliance, and open communication with the device manufacturer or study sponsor [2].

Cleanroom Evidence and Traceability Require Documentation

Not all medical components need cleanroom manufacturing; classification depends on the device's intended use and regulatory pathway [6]. When controlled environments are required, the evaluation should confirm validated cleanrooms at the necessary ISO classification, such as ISO Class 7 or 8, and review how the supplier continuously monitors and logs temperature, humidity, particulate counts, and pressure differentials [6]. Documented procedures for garbing, gowning, and personnel training, plus how molding machines are cleaned and maintained inside the controlled environment, are also part of the assessment [6]. A promise to build a cleanroom after winning the business should not substitute for existing, validated capacity [6].

Traceability evaluation asks whether the supplier can trace a finished part lot back to the raw material lot, processing equipment, operator, inspection records, and release status [6]. The standard production and history record package should be reviewed, along with data retention policies and retrieval speed during a regulatory inspection [6]. Medtronic's Supplier Quality Excellence Manual expects suppliers to manage sub-tier suppliers with controls commensurate with risk, ensuring that products use only authentic, conforming, and specified material [5]. The manual also expects documented procedures for calibration, control, and maintenance of measuring, inspection, and test equipment, with calibration traceable to recognized national or international standards [3].

Audit Architecture: MedAccred Versus QMS Audits

The MedAccred program is an industry-managed, consensus-driven approach administered by the Performance Review Institute, modeled on the Nadcap aerospace program [4]. A current valid quality system certification, such as ISO 13485, is required before scheduling a MedAccred accreditation audit [4]. Subscribing OEMs provide governance, determine audit criteria, have full access to audit findings, and determine who is granted accreditation [4]. Medical device OEM subscribers use the program to reduce the scope and frequency of audits at their plastics injection molder suppliers, with some eliminating interval audits unless there is a strong reason [1]. The program covers cable and wire harness, heat treating, plastics injection molding, extrusion, mechanical assembly, printed boards, printed circuit board assemblies, sterilization, sterile device packaging, and welding [4].

For an evaluation team, the practical question is whether a MedAccred accreditation can substitute for a proprietary on-site audit. The program's stated subscriber benefits include enhanced rigorous oversight of critical manufacturing processes, enhanced oversight of the supply chain, improved capability to meet FDA purchasing control requirements, and increased confidence that the supplier can consistently meet customer specifications and regulatory requirements [1]. Supplier benefits include improved product quality through compliance and adherence to plastics molding schedules, increased process efficiency, reduced scrap and rework, decreased frequency and number of audits, and insights from audits performed by injection molding subject-matter experts [1]. However, the evaluation should still confirm that the accreditation scope matches the specific component and process being sourced, since accreditation is process-specific rather than a blanket endorsement of all capabilities.

A Concrete Qualification Example

Consider a hypothetical evaluation of a molder for a polycarbonate housing on a Class II electromechanical device. The manufacturer of record first classifies the component: a housing failure could expose internal electronics but would not directly enter the patient, so the risk is moderate. The evaluation team then requests the supplier's ISO 13485 certificate scope and recency, FDA QMSR alignment, audit history, and CAPA processes [6]. The team asks for the Master Validation Plan and reviews the IQ/OQ/PQ records for a similar housing program, checking that machine settings in the production records fall within the validated process window with proper tolerances and process alarm settings [1].

The team also requests cleanroom environmental monitoring logs if the housing requires a controlled environment, and confirms the supplier's traceability from finished part lot to raw material lot, processing equipment, operator, inspection records, and release status [6]. The supplier's sub-tier control procedure for the polycarbonate resin is reviewed to confirm selection, evaluation and approval, product qualification, procurement, product acceptance, performance measurement and monitoring, nonconforming product and CAPA processes, and change control [5]. The team should also confirm that the supplier has documented procedures for calibration, control, and maintenance of measuring, inspection, and test equipment, with calibration traceable to recognized national or international standards [3]. If the supplier holds a current MedAccred Plastics Injection Molding accreditation, the team may reduce the scope of its own on-site audit, but it should still verify that the accreditation covers the specific molding process and material family. This example is a suggested workflow, not a tested protocol, and the actual acceptance criteria should be reviewed with quality and regulatory professionals before finalizing [6].